A
Arnon Nagler
Researcher at Sheba Medical Center
Publications - 1435
Citations - 51740
Arnon Nagler is an academic researcher from Sheba Medical Center. The author has contributed to research in topics: Transplantation & Hematopoietic stem cell transplantation. The author has an hindex of 98, co-authored 1316 publications receiving 44298 citations. Previous affiliations of Arnon Nagler include French Institute of Health and Medical Research & University of Paris.
Papers
More filters
Journal ArticleDOI
Peripheral blood stem cell graft compared to bone marrow after reduced intensity conditioning regimens for acute leukemia: a report from the ALWP of the EBMT.
Bipin N. Savani,Myriam Labopin,Didier Blaise,Dietger Niederwieser,Fabio Ciceri,Arnold Ganser,Renate Arnold,Boris V. Afanasyev,Stephane Vigouroux,Noel Milpied,Michael Hallek,Jan J. Cornelissen,Rainer Schwerdtfeger,Emmanuelle Polge,Frédéric Baron,Jordi Esteve,Norbert Claude Gorin,Christoph Schmid,Sebastian Giebel,Mohamad Mohty,Arnon Nagler +20 more
TL;DR: Despite the limitation of a retrospective registry-based study, it is found that peripheral blood grafts after reduced intensity conditioning regimens had better overall and leukemia-free survival than bone marrow grafts, however, there is an increase in chronic graft-versus-host disease after peripheralBlood grafts.
Journal ArticleDOI
Successful umbilical cord blood transplantation for Fanconi anemia using preimplantation genetic diagnosis for HLA-matched donor.
Bella Bielorai,Mark R. Hughes,Arleen D. Auerbach,Arnon Nagler,Ron Loewenthal,Gideon Rechavi,Amos Toren +6 more
TL;DR: It is reported that successful cord blood transplantation for a Fanconi anemia patient from his HLA‐matched sibling, born after PGD that included mutation analysis for FanconiAnemia and HLA typing is reported.
Journal ArticleDOI
Haploidentical transplantation is associated with better overall survival when compared to single cord blood transplantation: An EBMT-Eurocord study of acute leukemia patients conditioned with thiotepa, busulfan, and fludarabine
Federica Giannotti,Myriam Labopin,Roni Shouval,Jaime Sanz,William Arcese,Emanuele Angelucci,Jorge Sierra,Josep Maria Ribera Santasusana,Stella Santarone,Bruno Benedetto,Alessandro Rambaldi,Riccardo Saccardi,Didier Blaise,M. Carella,Vanderson Rocha,Vanderson Rocha,Vanderson Rocha,Frédéric Baron,Mohamad Mohty,Annalisa Ruggeri,Arnon Nagler +20 more
TL;DR: The results suggest that TBF-MAC might allow for a potent graft-versus-leukemia, regardless of the alternative donor type, and survival with NTD-Haplo may be better compared to SUCBT due to decreased NRM.
Journal ArticleDOI
Allogeneic stem cell transplantation in adult patients with acute myeloid leukaemia and 17p abnormalities in first complete remission: a study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT).
Xavier Poiré,Myriam Labopin,Johan Maertens,Ibrahim Yakoub-Agha,Didier Blaise,Norbert Ifrah,Gérard Socié,Tobias Gedde-Dhal,Nicolaas Schaap,Jan J. Cornelissen,Stephane Vigouroux,Jaime Sanz,Lucienne Michaux,Jordi Esteve,Mohamad Mohty,Arnon Nagler +15 more
TL;DR: Allogeneic SCT provides responses in about 25% of those patients transplanted in CR1, and the presence of a -5/5q- in addition to abn(17p) was significantly and independently associated with worse OS, LFS and higher RI.
Journal ArticleDOI
Effects of recombinant human granulocyte and granulocyte-macrophage colony-stimulating factors on neutrophil function following autologous bone marrow transplantation.
TL;DR: It is suggested that GM-CSF and G- CSF may enhance the depressed functional activity of neutrophils following ABMT.